U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. POSTPONED - FDA-NIH Rare Disease Day - 02/27/2025
  1. FDA Meetings, Conferences and Workshops

Meeting | Mixed

Event Title
POSTPONED - FDA-NIH Rare Disease Day
February 27 - 28, 2025

Postponed
Date:
February 27 - 28, 2025
Day1:
Thu, Feb 27
Day2:
Fri, Feb 28
Organized By:
Organizer

After much consideration, we are postponing FDA-NIH Rare Disease Day 2025 and will reschedule it to occur in the coming months. Rare Disease Day is important to all of us, and we want to make sure we can fully focus on the event to make it the best that it can be. We appreciate your understanding and thank you for your continued work raising awareness, developing cures and treatments, and offering resources that give hope to the millions of people in this country affected by rare diseases.

Rare Disease Day® takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. This year, the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration, both agencies within the Department of Health and Human Services (HHS), will sponsor a shared Rare Disease Day event as part of this global observance.

Event Details

 Meeting Information  

The 2025 FDA-NIH Rare Disease Day is a two-day meeting on Thursday, February 27 and Friday, February 28, 2025, from 10 a.m. to 4 p.m. EST each day. The meeting will take place online (virtually) and in-person in Bethesda, Maryland, on the NIH campus in the Natcher Conference Center. For more information about NIH campus security and how to get to NIH, please visit https://www.nih.gov/about-nih/visitor-information.

Registration is required for in-person and online attendance.

Choose the "Register Now" button above to request space for an in-person exhibit or poster at the meeting.

Meeting Goals

FDA-NIH Rare Disease Day aims to provide the rare disease community — patients, caregivers, families, patient advocate groups, researchers, clinicians, health care providers, and trainees/students — with information relevant to their lived experiences, including activities by FDA and NIH that promote research and product development for this underserved population.   

The goals of FDA-NIH Rare Disease Day are to: 

  • Demonstrate the NIH and FDA commitment to advancing research and regulatory support for people with rare diseases. 
  • Highlight NIH and FDA supported rare diseases research and the development of diagnostics and treatments. 
  • Initiate a mutually beneficial dialogue among the rare diseases community. 
  • Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts. 
  • Shine a spotlight on stories told by patients living with a rare disease, their caregivers, and their communities. 

FDA-NIH Rare Disease Day seeks to bring together a broad audience including patients, patient advocates, caregivers, health care providers, researchers, trainees, students, industry representatives, and government staff.

Back to Top